Have a question?
Open from 8am to 7pm Monday to FridayCall customer services
0345 54 32 600

Prices delayed by at least 15 minutes | Print

Global X Etfs Icav GLOBAL X GENOMICS & BIOTECHNOLOGY (GNOM)

Sell: $8.321|Buy: $8.363|Change: 0.02 (0.28%)

Open

$8.245

Previous close

$8.28

Trade high

$8.344

Income frequency

Year low

$4.86

Year high

$8.511

Replication method

Synthetic Replication

Volume

Type

ETF

UCITS

Yes

Dividend yield

–

Ongoing charge

0.5

ISIN

IE00BM8R0N95

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Asset allocation

Top 10 holdings

Holdings 12/12/2025	% of assets
Arrowhead Pharmaceuticals Inc	6.49
Illumina Inc	5.29
Guardant Health Inc	5.27
Praxis Precision Medicines Inc Ordinary Shares	5.13
Natera Inc	4.49
Moderna Inc	4.45
Vertex Pharmaceuticals Inc	4.01
BioMarin Pharmaceutical Inc	3.83
Avidity Biosciences Inc Ordinary Shares	3.83
Qiagen NV	3.56

Performance 30/11/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Fund	+ 0.28
Category	-
More...

Investment objective

The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the “Index”).

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Asset class

ETF

Morningstar rating^TM

Morningstar sustainability rating^TM

Morningstar Medalist Rating^TM

Morningstar analyst document

Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.